SCHEMBL24105201

SCHEMBL24105201

COc1ccc(-c2cnc3c(Nc4ccc(SC)cc4)nccn23)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 2/20 0.47
▸ TTK P33981 4/20 0.46
▸ AURKA O14965 4/20 0.45
▸ LMNA P02545 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ GSK3B P49841 1/20 0.42
▸ YES1 P07947 3/20 0.42
▸ AURKB Q96GD4 1/20 0.42
▸ MAPKAPK5 Q8IW41 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ ABL1 P00519 2/20 0.41
▸ NTRK1 P04629 2/20 0.41
▸ KDR P35968 2/20 0.41
▸ PIM1 P11309 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24105215 0.88 SRC (0.49) SRCTTKAURKALMNANPC1
SCHEMBL30371440 0.88 SRC (0.49) SRCTTKAURKALMNANPC1
SCHEMBL3466981 0.86 SRC (0.56) SRCTTKAURKALMNANPC1
SCHEMBL24105022 0.83 TTK (0.52) SRCTTKAURKANPC1RAB9A
SCHEMBL24105202 0.83 AURKA (0.55) SRCTTKAURKAGSK3BAURKB
SCHEMBL22122900 0.81 TTK (0.54) SRCTTKAURKAMAPKAPK5ALDH1A1
SCHEMBL24105039 0.81 AURKA (0.70) SRCTTKAURKASMN1; SMN2AURKB
SCHEMBL8246763 0.80 AURKA (0.67) SRCTTKAURKALMNANPC1
SCHEMBL30168171 0.80 EIF2AK4 (0.46) SRCTTKAURKAAURKBMAPKAPK5
SCHEMBL5408800 0.80 FLT3 (0.54) SRCTTKMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021249893-A1 NOVEL IMIDAZO-PYRAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2021-12-16 — — WO disclosed
Send feedback